Medical Science Pulse, cilt.16, sa.1, ss.33-37, 2022 (Hakemli Dergi)
Background: Wedge resection and enucleation are the most commonly preferred surgical modalities for
the treatment of pulmonary hamartomas. There is a concern about the safety and efficacy of enucleation for
a pulmonary hamartoma.
Aim of the study: To compare wedge resection and enucleation for the surgical treatment of pulmonary
hamartomas.
Material and methods: We retrospectively analyzed the data from patients who were surgically diagnosed
with pulmonary hamartoma between January 2014 and December 2019. We obtained data on clinical findings, radiological features, surgical modality, postoperative complications, and follow-up results from the
hospital electronic database. We compared all these features in the patients who underwent wedge resection
with those who received enucleation.
Results: A total of 18 patients with pulmonary hamartoma were analyzed. The mean age of the patients
was 60.56±9.25 years and 10 (55.6%) were male. Twelve (66.7%) patients had no respiratory symptoms.
Ten (55.6%) of the patients underwent wedge resection and 8 (54.4%) patients had enucleation. There were
no significant differences in age, gender, symptom distribution, prolonged air leakage, hospital stay length,
intensive care unit stay length, mortality, or relapse rate between the patients with wedge resection and enucleation. Nodule size, calcification, metabolic activity, central or peripheral location, and lobar distribution
were also similar.
Conclusions: We observed that there were no significant differences in the postoperative complications,
hospital stay length, mortality or relapse between the patients with wedge resection and enucleation. Minimal parenchymal damage and resection should be the aim of surgical interventions for benign lung diseases.
Therefore, we believe that enucleation should be the first choice for the surgical treatment pulmonary hamartomas.